Applied DNA Sciences, Inc. (APDN)

Market Cap	8.66M
Revenue (ttm)	3.74M
Net Income (ttm)	-23.59M
Shares Out	55.19M
EPS (ttm)	-2.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,904,549
Open	0.161
Previous Close	0.162
Day's Range	0.150 - 0.166
52-Week Range	0.120 - 14.400
Beta	0.36
Analysts	Strong Buy
Price Target	1.50 (+855.41%)
Earnings Date	Feb 13, 2025

About APDN

Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-base...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1983
• Employees: 48
• Stock Exchange: NASDAQ
• Ticker Symbol: APDN
• Website: https://www.adnas.com

Financial Performance

In 2024, Applied DNA Sciences's revenue was $3.43 million, a decrease of -74.33% compared to the previous year's $13.37 million. Losses were -$7.23 million, -27.36% less than in 2023.

Analyst Forecast

According to one analyst, the rating for APDN stock is "Strong Buy" and the 12-month stock price forecast is $1.5.

Price Target

$1.5

(855.41% upside)

Analyst Consensus: Strong Buy